Myomo inks Italian sales deal

Myomo recently announced that it has signed a sales and service agreement with Progettiamo Autonomia Robotics (PAR) to market the MyoPro in Italy.

Myomo is a wearable medical robotics company that gives functionality to people who have neurological disorders and upper limb paralysis. PAR is also focused on neurological pathologies and delivering devices for orthopedic rehabilitation.

“Progettiamo Autonomia Robotics aims to become the leading robotics company in Italy,” Cristian Iori, CEO of PAR, said in a press release. “We are well known in the rehabilitation market where our focus is innovation and we are supported with a large commercial network of partners. Myomo offers us a great opportunity to extend our catalog, addressing a broader range of patients and conditions and delivering better service to rehabilitation facilities and direct to patients.”

Myomo’s MyoPro is a powered upper limb orthosis that is designed to support the arm and restore function to weakened or paralyzed arms in people who have had a CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular diseases or injury.

“This agreement with PAR enables Myomo to continue to expand our footprint in Europe, where we are already working with orthotics and prosthetics practices and rehabilitation facilities in Denmark, Germany and U.K. PAR represents exactly the kind of innovative partner with whom we expect to build a solid global business over time.”

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW